ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 66 filers reported holding ONCOCYTE CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $15,936 | -18.9% | 21,830 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $19,640 | +11.4% | 21,830 | +84.5% | 0.00% | 0.0% |
| Q1 2022 | $17,627 | -34.6% | 11,830 | -4.8% | 0.00% | 0.0% |
| Q4 2021 | $26,973 | -39.3% | 12,430 | -0.4% | 0.00% | -50.0% |
| Q3 2021 | $44,429 | -38.0% | 12,480 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $71,635 | +10.6% | 12,480 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $64,771 | +4416.8% | 12,480 | +1980.0% | 0.00% | – |
| Q4 2020 | $1,434 | +57.6% | 600 | -8.4% | 0.00% | – |
| Q3 2020 | $910 | -83.3% | 655 | -77.1% | 0.00% | – |
| Q2 2020 | $5,453 | -22.0% | 2,855 | 0.0% | 0.00% | -100.0% |
| Q1 2020 | $6,995 | +129.4% | 2,855 | +110.7% | 0.00% | – |
| Q4 2019 | $3,049 | +7.1% | 1,355 | 0.0% | 0.00% | – |
| Q3 2019 | $2,846 | – | 1,355 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 1,093,219 | $6,833,000 | 1.15% |
| HUNTINGTON NATIONAL BANK | 10 | $0 | 0.00% |
| CITIGROUP INC | 642 | $4,000 | 0.00% |
| Sonora Investment Management, LLC | 50 | $0 | 0.00% |
| BARCLAYS PLC | 206 | $1,000 | 0.00% |
| BLACKROCK ADVISORS LLC | 96 | $1,000 | 0.00% |